Skip to content
Open access · US-GOV via ClinicalTrials.gov Clinical trial

A Multicenter, Randomized, Double-Blind, Placebo Controlled Flexible Dose Study of Aripiprazole in the Treatment of Patients With Psychosis Associated With Dementia of Alzheimer's Type

Authors not listed

Otsuka Pharmaceutical Development & Commercialization, Inc. · 2000

Abstract

The primary objective of the study is to compare the efficacy of aripiprazole with placebo in patients with psychosis associated with Alzheimer's dementia.

◌ CITATION ONLY
Full text is not openly licensed for redistribution here. Read it at the source:

Read at source →

Provenance

Source
ClinicalTrials.gov
Canonical
link ↗
Fetched
2026-11-12 MST

Cite this

APA
Anonymous. (2000). A Multicenter, Randomized, Double-Blind, Placebo Controlled Flexible Dose Study of Aripiprazole in the Treatment of Patients With Psychosis Associated With Dementia of Alzheimer's Type. <em>Otsuka Pharmaceutical Development & Commercialization, Inc.</em>. https://clinicaltrials.gov/study/NCT01438060
Vancouver
Anonymous. A Multicenter, Randomized, Double-Blind, Placebo Controlled Flexible Dose Study of Aripiprazole in the Treatment of Patients With Psychosis Associated With Dementia of Alzheimer's Type. Otsuka Pharmaceutical Development & Commercialization, Inc.. 2000.
BibTeX
@misc{anon2000AMulti, title = {A Multicenter, Randomized, Double-Blind, Placebo Controlled Flexible Dose Study of Aripiprazole in the Treatment of Patients With Psychosis Associated With Dementia of Alzheimer's Type}, author = {Anonymous}, journal = {Otsuka Pharmaceutical Development & Commercialization, Inc.}, year = {2000}, }

Research neighborhood

References, citing works, and semantically nearest findings. Click a node to open it.

Related findings